Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare Conference
05 Giugno 2024 - 1:00PM
Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a
commercial-stage biotechnology company, today announced that the
Company will participate in the Goldman Sachs 45th Annual Global
Healthcare Conference on June 11, 2024, in Miami. Krish S.
Krishnan, Chairman and Chief Executive Officer, will take part in a
fireside chat scheduled at 10:40 am ET and host investor meetings
throughout the day.
A webcast of the presentation will be available here beginning
at 10:40 am ET on Tuesday, June 11, 2024 and will be posted on the
Investors section of the Company’s website.
About Krystal Biotech, Inc.
Krystal Biotech, Inc. (NASDAQ: KRYS) is a commercial-stage
biotechnology company focused on the discovery, development and
commercialization of genetic medicines to treat diseases with high
unmet medical needs. VYJUVEK® is the Company’s first commercial
product, the first-ever redosable gene therapy, and the first
medicine approved by the FDA for the treatment of dystrophic
epidermolysis bullosa. The Company is rapidly advancing a robust
preclinical and clinical pipeline of investigational genetic
medicines in respiratory, oncology, dermatology, ophthalmology, and
aesthetics. Krystal Biotech is headquartered in Pittsburgh,
Pennsylvania. For more information, please visit
http://www.krystalbio.com, and follow @KrystalBiotech on LinkedIn
and X (formerly Twitter).
CONTACTInvestors and
Media:Stéphane PaquetteKrystal
Biotechspaquette@krystalbio.com
Grafico Azioni Krystal Biotech (NASDAQ:KRYS)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni Krystal Biotech (NASDAQ:KRYS)
Storico
Da Set 2023 a Set 2024